Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Ex-vivo simple models are powered tools to study cardiac hypertrophy. It is possible to control the activation of critical genes and thus test the effects of drug therapies before the in vivo tests. A zebrafish cardiac hypertrophy developed by 500 μM phenylephrine (PE) treatment in ex vivo culture has been demonstrated to activate the essential expression of the embryonal genes. These genes are the same as those described in several previous pieces of research on hypertrophic pathology in humans. The efficacy of the chemical drug Blebbistatin (BL) on hypertrophy induced ex vivo cultured hearts is studied in this research. BL can inhibit the myosins and the calcium wave in counteracting the hypertrophy status caused by PE. Samples treated with PE, BL and PE simultaneously, or pre/post-treatment with BL, have been analysed for the embryonal gene activation concerning the hypertrophy status. The qRTPCR has shown an inhibitory effect of BL treatments on the microRNAs downregulation with the consequent low expression of essential embryonal genes. In particular, BL seems to be effective in blocking the hyperplasia of the epicardium but less effective in myocardium hypertrophy. The model can make it possible to obtain knowledge on the transduction pathways activated by BL and investigate the potential use of this drug in treating cardiac hypertrophy in humans.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bbadis.2022.166471 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Long-term hydroxychloroquine use resulting in cardiomyopathy and conduction abnormalities: a case report.
Eur Heart J Case Rep
September 2025
Advanced Heart Failure and Cardiac Transplant Service, Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch, WA 6150, Australia.
Background: Diagnosing the cause of undifferentiated left ventricular hypertrophy (LVH) in a patient with progressive heart failure symptoms can present a diagnostic challenge, with potential for both inherited and acquired aetiologies. Hydroxychloroquine-induced cardiomyopathy (HCQ-CM) is a rare complication of long-term hydroxychloroquine use. This case report highlights its clinical presentation, key differential diagnoses, and treatment strategies.
View Article and Find Full Text PDFAdropin as a therapeutic candidate for HFpEF: evidence of oxidative stress mitigation via Nrf2/HO-1 signaling.
Lipids Health Dis
September 2025
Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Background: Heart failure with preserved ejection fraction (HFpEF), which accounts for more than half of all heart failure cases worldwide, has emerged as a major public health challenge characterized by substantial morbidity and mortality rates. As adropin is a key regulator of cardiovascular and metabolic homeostasis, this study investigated its therapeutic effects against HFpEF pathogenesis.
Methods: C57BL/6 mice were fed a high-fat diet (60% fat-derived calories) with NG-nitro-L-arginine methyl ester (L-NAME, 0.
Diabetes mellitus exacerbates cardiovascular remodeling in elderly Chinese by affecting aortic diameter and pulsatile load.
Sci Rep
September 2025
Department of Geriatrics, The First Hospital of China Medical University, 155 Nanjing North Street, Shenyang, 110001, China.
Cardiovascular health is negatively impacted by arterial stiffening, which increases pulsatile load and elevates left ventricular workload. Aortic dilatation may compensate for the pulsatile overload resulting from arterial stiffening. Previous studies have shown a negative correlation between diabetes and aortic diameter, suggesting that diabetes may impair aortic dilatation and thereby compromise compensatory buffering capacity.
View Article and Find Full Text PDFAortic valve replacement and mortality in asymptomatic individuals with severe aortic stenosis and left ventricular hypertrophy.
Eur J Cardiothorac Surg
September 2025
Heart and Vascular Institute and Department of Medicine, Mass General Brigham, Harvard Medical School, 55 Fruit Street, Boston, Massachusetts, 02138, USA.
Objectives: Indications for aortic valve replacement (AVR) in severe asymptomatic aortic stenosis (AS) differ for individuals with normal versus low or decreasing left ventricular ejection fraction (LVEF). Conceptually, the development of left ventricular hypertrophy (LVH) could also indicate ventricular injury and potential need for earlier AVR.
Methods: Initially, 1 232 492 echocardiography reports from 12 hospitals were identified; then previously validated, open-source natural language processing modules were applied to identify aortic gradients, LVEF, and the presence of LVH.
Prevalence and progression of P-wave abnormalities in patients with atrial fibrillation.
Heart Rhythm
April 2025
Heart Center, Turku University Hospital and University of Turku, Turku, Finland. Electronic address:
Background: Various electrocardiographic P-wave indices are associated with cardiovascular comorbidities, such as atrial fibrillation (AF) and stroke. However, information on their stability is limited.
Objective: This study explored the prevalence and progression of P-wave abnormalities (PWAs) as well as their risk factors in an AF population.